The Anti-Cardiolipin IgG Antibody Test is a blood test commonly used to help diagnose autoimmune disorders like Antiphospholipid Syndrome (APS) and assess the risk of blood clotting disorders.
Anti-cardiolipin antibodies are a type of antiphospholipid antibody that targets cardiolipins, which are phospholipids, or fat molecules, found in cell membranes. High levels of anti-cardiolipin antibodies can increase the risk of clotting disorders and complications during pregnancy, such as Antiphospholipid Pregnancy Syndrome.
The Anti-Cardiolipin Antibody Test measures the presence and level of anti-cardiolipin IgG antibodies in the blood. These antibodies can cause the immune system to mistakenly attack cardiolipins, which can disrupt normal blood clotting. A positive anti-cardiolipin antibody test may indicate Antiphospholipid Syndrome (APS), which can increase the risk of recurrent blood clots, pregnancy complications, and cardiovascular events.
Identifying Risk of Blood Clotting Disorders: Elevated levels of Anti-Cardiolipin IgG are associated with an increased risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
Diagnosing Antiphospholipid Syndrome (APS): A positive Anti-Cardiolipin test can indicate APS, which is often linked to autoimmune diseases like Systemic Lupus Erythematosus (SLE).
Monitoring Pregnancy Health: In pregnancy, high levels of anti-cardiolipin antibodies can result in Antiphospholipid Pregnancy Syndrome, which increases the risk of miscarriage and other complications.
Assessing Stroke and Cardiovascular Risk: Patients with high levels of anti-cardiolipin antibodies may have a heightened risk of stroke, heart attacks, and other cardiovascular issues.
The Anti-Cardiolipin IgG normal range can vary by lab, but typically levels are categorized as follows:
Negative/Low Risk: 0-15 GPL (IgG Phospholipid units). Moderate/Borderline Risk: 15-40 GPL. High Risk: >40 GPL
Positive Anti-Cardiolipin Antibody results at moderate to high levels, especially when accompanied by symptoms of blood clotting or recurrent miscarriages, may suggest APS. For patients without symptoms, a single positive result might warrant monitoring rather than immediate treatment.
Individuals who may benefit from the Anti-Cardiolipin Antibody Test include Those with recurrent blood clotting events or thrombosis without a clear cause. Patients diagnosed with autoimmune disorders like lupus. Women experience multiple unexplained miscarriages or pregnancy complications. Individuals with a family history of clotting disorders or antiphospholipid syndrome.
1. Advanced Testing Capabilities: Diagnopein in Pune uses advanced equipment to provide precise and reliable anti-Cardiolipin IgG test results, helping you make informed decisions about your health.
2. Expert Clinical Guidance: Our specialists are well-versed in autoimmune conditions and can provide expert interpretations to help understand your test results in the context of your health.
3. Patient-Centered Approach: Diagnopein ensures a comfortable, supportive experience from test scheduling to result delivery, prioritizing patient needs and providing timely assistance.
4. Convenience and Accessibility: Our accessible testing centers make it easy to undergo essential testing like the Anti-Cardiolipin Antibody Test, with rapid results to minimize waiting time.
Treatment often involves blood-thinning medications and lifestyle changes, particularly for individuals with APS or a high clotting risk. Consult your doctor for personalized advice.
A positive anti-cardiolipin IgG test can indicate an elevated risk of blood clots, Antiphospholipid Syndrome (APS), or other autoimmune disorders.
Those with a history of unexplained blood clots, recurrent miscarriages, or autoimmune diseases like lupus may benefit from this test.
The normal range is generally from 0 to 15 GPL. Levels above this may indicate a moderate to high risk for clotting disorders.
This is a complication linked to antiphospholipid antibodies, such as anti-cardiolipin antibodies, which can cause recurrent pregnancy loss, preterm birth, or other pregnancy complications.
The test involves a blood draw from a vein in the arm and is quick, usually taking only a few minutes to complete.
Yes, elevated anti-cardiolipin antibody levels are associated with an increased risk of stroke and other cardiovascular issues due to clotting disorders.
Yes, levels may vary over time, and a single positive result may not indicate APS. Repeated tests may be recommended to confirm the diagnosis.
